Profile: Heptest Laboratories, Inc. manufactures factor Xa_ bovine, bovine thrombin and heparin assay. The anti-factor Xa is a method to determine the appropriate dose of heparin during pregnancy. Our Heptest® is a suitable method for monitoring heparin during pregnancy. The synthetic indirect & direct factor Xa inhibitors, and direct thrombin inhibitors are developed to improve the benefit ratio of anticoagulant therapy of patients.
3 Products/Services (Click for related suppliers)
|
| • Heparin Assay (FDA Code: KFF / 864.7525) A heparin assay is a device used to determine the level of the anticoagulant heparin in the patient's circulation. These assays are quantitative clotting time procedures using the effect of heparin on activated coagulation factor X (Stuart factor) or procedures based on the neutralization of heparin by protamine sulfate (a protein that neutralizes heparin). |
| • Qualitative and Quantitative Factor Deficiency Test (FDA Code: GGP / 864.7290) A factor deficiency test is a device used to diagnose specific coagulation defects, to monitor certain types of therapy, to detect coagulation inhibitors, and to detect a carrier state (a person carrying both a recessive gene for a coagulation factor deficiency such as hemophilia and the corresponding normal gene). |
| • Thrombin Time Test (FDA Code: GJA / 864.7875) A thrombin time test is a device used to measure fibrinogen concentration and detect fibrin or fibrinogen split products for the evaluation of bleeding disorders. |